Analgesics (Pharmacies) - Guatemala

Revenue in the Analgesics market is projected to reach US$72.78m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 9.31%, resulting in a market volume of US$113.60m by 2029.
In global comparison, most revenue will be generated China (US$5.03bn in 2024).
In relation to total population figures, per person revenues of US$3.96 are generated in 2024.

Definition:
The Analgesics market encompasses non-prescription natural and synthetic non-opioid analgesics sold through pharmacies. These include well-known products such as Paracetamol, Ibuprofen, Aspirin, Diclofenac, and various pain-relieving preparations. The market's scope varies with national legislation concerning opioid analgesics, with legal opioids being incorporated based on respective state regulations. In countries like Germany, Austria, and Switzerland, opioid analgesics are included if they comply with narcotics law limitations and do not necessitate a prescription. The analgesics are presented in forms like pills, capsules, gels, and ointments. However, the market excludes prescription medications (e.g., morphine), anesthetics, and homeopathic remedies. Notable top-selling painkillers encompass Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol, and ASS. This market exclusively covers product sales through pharmacies.

Additional information:
The Analgesics market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics (Pharmacies) market in Guatemala is experiencing steady growth due to increasing customer preferences for over-the-counter pain relief medications, along with several local special circumstances and underlying macroeconomic factors. Customer preferences in the Analgesics (Pharmacies) market in Guatemala are driving the growth of this sector. Consumers in Guatemala are increasingly seeking convenient and affordable solutions for pain relief. This has led to a rise in the demand for over-the-counter analgesics, as they are easily accessible in pharmacies without the need for a prescription. Additionally, customers prefer analgesics that offer quick and effective relief from pain, making them more inclined towards products with proven efficacy. Trends in the market reflect the growing demand for analgesics in Guatemala. The market is witnessing an expansion in the range of analgesic products available, with pharmaceutical companies introducing new formulations and variations to cater to different customer needs. For example, there is an increasing availability of analgesics in multiple dosage forms such as tablets, capsules, creams, and gels, providing customers with a wider choice of options. Furthermore, there is a growing trend towards natural and herbal analgesics, as customers are becoming more conscious of the ingredients used in these products. Local special circumstances also contribute to the development of the Analgesics (Pharmacies) market in Guatemala. The country has a high prevalence of chronic diseases such as arthritis and back pain, which require long-term pain management. This creates a sustained demand for analgesics, as patients rely on these medications to alleviate their symptoms. Additionally, Guatemala has a large population of elderly individuals who often experience age-related pain, further driving the demand for analgesics. Underlying macroeconomic factors are also influencing the growth of the Analgesics (Pharmacies) market in Guatemala. The country's improving economic conditions have resulted in an increase in disposable income, allowing consumers to spend more on healthcare products. As a result, the demand for analgesics has seen a boost, as individuals are willing to invest in their well-being. Furthermore, the expanding middle class in Guatemala has contributed to the growth of the market, as this segment of the population has greater access to healthcare services and can afford to purchase analgesics. In conclusion, the Analgesics (Pharmacies) market in Guatemala is developing due to customer preferences for over-the-counter pain relief medications, along with local special circumstances such as the prevalence of chronic diseases and an aging population. The market is also influenced by underlying macroeconomic factors, including improved economic conditions and a growing middle class. These factors together contribute to the steady growth of the Analgesics (Pharmacies) market in Guatemala.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.